Neil Mitchell says he’s been keeping a close eye on the Johnson and Johnson vaccine trial, which shapes as a possible “game-changer” against COVID-19.

It’s claimed as many as one billion doses could be produced and it’s just a single shot vaccine.

It’s also reported strong results against a range of variants.

“Australia hasn’t got a deal for this yet,” Neil Mitchell said.

He played comments from Professor Luke O’Neill, immunologist and biochemist from Trinity College in Ireland.

“When you hear that, it’s a pretty strong recommendation,” Neil Mitchell said in response.

Click PLAY below to hear more on 3AW